This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Gestational diabetes update – May 2017

gestational diabetes baby and phoneThe commercialisation of the GDm-Health system was finalised in 2017, with the system procured by Drayson Technologies. Three agreements have been signed between Drayson Technologies, the University of Oxford and Oxford University Hospitals NHS Foundation Trust to collaborate on the development, testing and future commercialisation of GDm-Health. Drayson Technologies will support the wider testing of GDm-Health in up to four additional NHS Trusts across the UK in 2017/18 prior to taking over responsibility under an exclusive licence agreement for managing the wider deployment and commercialisation of this pioneering product across the NHS.